Puas yog NHS npog kev kho mob qog noj ntshav zes qe menyuam?

Cov txheej txheem:

Puas yog NHS npog kev kho mob qog noj ntshav zes qe menyuam?
Puas yog NHS npog kev kho mob qog noj ntshav zes qe menyuam?
Anonim

Raws li Lynparza cov ntsiab lus ntawm cov yam ntxwv ntawm cov khoom lag luam, nws yog siv ua ke nrog bevacizumab hauv cov neeg laus cov neeg mob uas muaj qib high-qib epithelial zes qe menyuam qog noj ntshav uas tau teb tom qab ua tiav thawj kab platinum-based chemotherapy ua ke nrog bevacizumab thiab nws. mob qog noj ntshav yog txuam nrog qhov zoo homologous recombination deficiency (HRD) raws li txoj cai, txhais tau tias yog BRCA 1/2 kev hloov pauv thiab / lossis genomic instability. Kuv poob rau hauv qhov kev xav no thiab kuv cov lus nug yog: Puas yog NHIF them nyiaj rov qab rau bevacizumab hauv kev sib xyaw nrog Linparza, lossis tus neeg mob yuav tsum them rau nws?

YRadostina Ivaylova, Sofia

Hais txog koj tus mob tam sim no, Lynparza tau them rov qab rau cov lus qhia hauv qab no:

• Monotherapy rau kev saib xyuas kev kho mob ntawm cov neeg laus cov neeg laus uas muaj platinum-rhiab heev relapsed, qib siab epithelial zes qe menyuam qog noj ntshav uas teb (ua tiav los yog ib feem teb) rau platinum-based chemotherapy;

• Monotherapy rau kev kho mob ntawm cov neeg laus cov neeg laus uas muaj siab heev (FIGO theem III thiab IV) qib siab epithelial zes qe menyuam qog noj ntshav nrog BRCA1/2 kev hloov pauv (germline thiab / lossis somatic) uas tau teb (ua tiav lossis ib nrab cov lus teb)) tom qab ua tiav thawj kab platinum-based chemotherapy.

Kev sib xyaw thiab kev nyeem ntawv koj tau teev tseg tsis tuaj yeem thim rov qab. Kev suav thiab tsis suav nrog cov khoom siv tshuaj nyob rau hauv Daim Ntawv Teev Tshuaj Zoo (PLS), nrog rau kev ntxiv cov tshuaj kho tshiab rau cov khoom siv tshuaj uas twb muaj lawm, yog nyob rau hauv kev muaj peev xwm ntawm National Council rau Nqi thiab Kev Them Rov Qab ntawm Cov Khoom Siv Tshuaj, raws li Txoj Cai Lij Choj Tshuaj Kho Mob hauv Tib Neeg Tshuaj.

Pom zoo: